Dodds Wealth’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$712K Sell
2,802
-457
-14% -$107K 0.16% 33
2026
Q1
$797K Buy
3,259
+221
+7% +$51.5K 0.2% 30
2025
Q4
$629K Buy
3,038
+1
+0% +$198 0.15% 35
2025
Q3
$563K Buy
3,037
+1
+0% +$171 0.14% 34
2025
Q2
$464K Sell
3,036
-540
-15% -$83K 0.12% 36
2025
Q1
$593K Buy
3,576
+482
+16% +$75.4K 0.19% 36
2024
Q4
$449K Buy
3,094
+1
+0% +$155 0.14% 38
2024
Q3
$496K Sell
3,093
-307
-9% -$48.9K 0.17% 39
2024
Q2
$500K Hold
3,400
0.2% 34
2024
Q1
$538K Buy
3,400
+21
+0.6% +$3.34K 0.22% 33
2023
Q4
$530K Buy
+3,379
New +$518K 0.27% 32

Other funds holding JNJ

Dodds Wealth's JNJ Position: Q2 2026 in Review

Dodds Wealth reduced its Johnson & Johnson (JNJ) stake by 14% in Q2 2026, selling an estimated $107K and leaving 2,802 shares worth $712K. The position accounts for 0.16% of the portfolio, ranked #33.

Dodds Wealth first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. The position peaked at $797K in Q1 2026. 4,649 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Dodds Wealth held 2,802 shares of Johnson & Johnson worth $712K as of Q2 2026.
  • Dodds Wealth sold 457 Johnson & Johnson shares in Q2 2026, an estimated $107K.
  • Johnson & Johnson made up 0.16% of Dodds Wealth's portfolio in Q2 2026, its #33 holding.
  • Dodds Wealth first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • Dodds Wealth's Johnson & Johnson position peaked at $797K in Q1 2026.
  • 4,649 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Dodds Wealth's 13F filing for Q2 2026, filed 6 Aug 2026.